Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001574251-19-000001
Filing Date
2019-05-24
Accepted
2019-05-23 17:52:15
Documents
1
Effectiveness Date
2019-05-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7190
  Complete submission text file 0001574251-19-000001.txt   8197
Mailing Address 4317 DUNNING LANE AUSTIN TX 78746
Business Address 4317 DUNNING LANE AUSTIN TX 78746 (512) 329-6360
Mati Therapeutics Inc. (Filer) CIK: 0001574251 (see all company filings)

EIN.: 462000931 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-340303 | Film No.: 19851373